Coalition for Epidemic Preparedness innovations
room Marcus Thranes Gate 2, 0473 Oslo
arrow_back See all Activities

Research and development of vaccines

IATI Identifier: NO-BRC-917687811-CEPI_02

Published on IATI
  • date_range Aug 30, 2016
  • autorenew Implementation (Status)

CEPI’s vision is a world in which epidemics and pandemics are no longer a threat to humanity. Going into the strategic period from 2022-2026, termed “CEPI 2.0”, CEPI aims to raise the bar to develop and scale vaccines and other promising biologic countermeasures even faster. The R&D community has moved with unprecedented speed in response to COVID-19, developing biological interventions like vaccines and monoclonal antibodies in less than 12 months. While these achievements are historic, what the world needs to avert the consequences of future epidemics and pandemics are countermeasures developed even faster. CEPI’s mission is to accelerate the development of vaccines and other biologic countermeasures against epidemic and pandemic threats so they can be accessible to all people in need. CEPI believes safe and effective vaccine in 100 days from the moment that a pathogen is sequenced and/ or the need for a vaccine is recognised to initial availability for use should be the aspiration. Over the strategic period, CEPI aims to invest USD 3.5 billion across three overall strategic objectives:

more_horiz
Sectors:
  • Infectious disease control

Participating Organisations

International AIDS Vaccine Initiative International NGO Implementing
IDT biologica Private Sector Implementing
Inovio Pharmaceuticals Private Sector Implementing
University of Oxford, The Academic, Training and Research Implementing
Themis Bioscience Private Sector Implementing
University of Tokyo Academic, Training and Research Implementing
CureVac Private Sector Implementing
Imperial College Academic, Training and Research Implementing
University of Queensland Academic, Training and Research Implementing
PATH International NGO Implementing
Aurobindo Private Sector Implementing
Public Health Vaccines Private Sector Implementing
Emergent BioSolutions Private Sector Implementing
Colorado State University Academic, Training and Research Implementing
International Vaccines Institute International NGO Implementing
Larissa Other Implementing
Valneva Private Sector Implementing
BNITM Academic, Training and Research Implementing
LSHTM Academic, Training and Research Implementing
University of Antwerpen Academic, Training and Research Implementing
Epicentre National NGO Implementing
Dalhousie Univesity Academic, Training and Research Implementing
FIND International NGO Implementing
Janssen Private Sector Implementing
NIBSC Other Public Sector Implementing
Tulane University Academic, Training and Research Implementing
University of North-Carolina Academic, Training and Research Implementing
Nigeria NCDC Other Public Sector Implementing
Benin FORS Academic, Training and Research Implementing
Norstat Norge Private Sector Funding
Norstat Denmark Private Sector Funding
Republic of Korea Government Funding
Government of Malaysia Government Funding
Taskforce for Global Health National NGO Implementing
University of Queensland Academic, Training and Research Implementing
Wageningen University & Research - Stichting Wageningen Research Academic, Training and Research Implementing
University of Pittsburgh Academic, Training and Research Implementing
Integrum Private Sector Implementing
Robert Koch Institute Academic, Training and Research Implementing
P-95 Private Sector Implementing
MERCK Private Sector Implementing
Technical University of Mombasa Academic, Training and Research Implementing
Medicines and Healthcare products Regulatory Agency (MHRA) Other Public Sector Implementing
Universiti Malaya Academic, Training and Research Implementing
Université Gamal Abdel Nasser de Conakry Academic, Training and Research Implementing
Connected DMV National NGO Implementing
Zalgen Labs Private Sector Implementing
Clover Biopharmaceuticals Private Sector Implementing
VBI Vaccines Inc. Private Sector Implementing
Shanghai Zerun Biotechnology Co., Ltd. Private Sector Implementing
MigVax Ltd Private Sector Implementing
Affinivax, Inc. Private Sector Implementing
BioNet-Asia Co.,Ltd. Private Sector Implementing
Public Health England Other Public Sector Implementing
Defence Science and Technology Laboratory Other Public Sector Implementing
UK - Department of Health and Social Care (DHSC) Government Implementing
Aga Khan University Academic, Training and Research Implementing
Medigen Vaccine Biologics Corp. Private Sector Implementing
Nuova Ompi S.r.l Private Sector Implementing
Dynavax Private Sector Implementing
International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) Academic, Training and Research Implementing
Viroclinics Biosciences B.V Private Sector Implementing
National Autonomous University of Mexico Academic, Training and Research Implementing
THSTI Academic, Training and Research Implementing
Nexelis Private Sector Implementing
Government of Australia Government Funding
The Government of Singapore Government Funding
SK bioscience Private Sector Implementing
Panacea Biotec Private Sector Implementing
Diosynvax Ltd Private Sector Implementing
NEC OncoImmunity AS Private Sector Implementing
Wellcome LEAP Private Sector Implementing
UNITE Global Parliamentarians Network International NGO Implementing
BERC Africa International NGO Implementing
United States Government Funding
University of Hong Kong Academic, Training and Research Implementing
Gritstone bio, Inc. Private Sector Implementing
International Vaccines Institute International NGO Implementing
Vaxxinity, Inc. Private Sector Implementing
Aurum Institute National NGO Implementing
The Government of Austria Government Funding
Government of Germany Government Funding
The Government of Italy Government Funding
European Commission - International Partnerships Other Public Sector Funding
Government of Canada Government Funding
The Government of Finland Government Funding
Government of Indonesia Government Funding
Nikkei Inc Japan Private Sector Funding
Government of New Zealand Government Funding
Bill and Melinda Gates Foundation Foundation Funding
University of Saskatchewan’s (USask) Vaccine and Infectious Disease Organization (VIDO) Academic, Training and Research Implementing
Murdoch Children’s Research Institute (MCRI) Academic, Training and Research Implementing
Harvard Medical School Academic, Training and Research Implementing
UK Health Security Agency Government Implementing
Bharat Biotech Private Sector Implementing
Sabin Vaccine Institute International NGO Implementing
University of British Columbia Academic, Training and Research Implementing
Mutala Research National NGO Implementing
The University of Texas Medical Branch Academic, Training and Research Implementing

Transaction

Transaction Value Provider
Receiver
Type Date
12,180,000 USD Provider N/A Receiver N/A Disbursement
date_range Sep 30, 2022
1,164,400 USD Government of New Zealand Receiver N/A Incoming Funds
date_range Sep 30, 2022
3,879,135 USD Bill and Melinda Gates Foundation Receiver N/A Incoming Funds
date_range Sep 30, 2022
31,690,000 USD Provider N/A Receiver N/A Disbursement
date_range Aug 31, 2022
19,759,803 USD European Commission Receiver N/A Incoming Funds
date_range Aug 31, 2022
40,628 USD Other investors Receiver N/A Incoming Funds
date_range Jul 31, 2022
10,184,336 USD European Commission Receiver N/A Incoming Funds
date_range Jul 31, 2022
1,939,955 USD Government of Canada Receiver N/A Incoming Funds
date_range Jul 31, 2022
2,084,854 USD Government of Finland Receiver N/A Incoming Funds
date_range Jul 31, 2022
20,449,898 USD Government of Germany Receiver N/A Incoming Funds
date_range Jul 31, 2022
6,690,000 USD Provider N/A Receiver N/A Disbursement
date_range Jul 31, 2022
1,000,000 USD Government of Indonesia Receiver N/A Incoming Funds
date_range Jul 31, 2022
1,677,325 USD Government of Austria Receiver N/A Incoming Funds
date_range Jun 30, 2022
4,206,984 USD Government of Italy Receiver N/A Incoming Funds
date_range Jun 30, 2022
62,663,185 USD Government of Germany Receiver N/A Incoming Funds
date_range Jun 30, 2022
14,340,000 USD Provider N/A Receiver N/A Disbursement
date_range Jun 30, 2022
600,000 USD Provider N/A Government of Singapore Incoming Funds
date_range May 31, 2022
33,000,000 USD Provider N/A Receiver N/A Disbursement
date_range May 31, 2022
1,616 USD Other investors Receiver N/A Incoming Funds
date_range Apr 30, 2022
79,900,000 USD Provider N/A Receiver N/A Disbursement
date_range Apr 30, 2022
13,000,000 USD Provider N/A Receiver N/A Disbursement
date_range Mar 31, 2022
3,000,000 USD Government of the Republic of Korea Receiver N/A Incoming Funds
date_range Mar 31, 2022
50,000,000 USD Government of the United States of America Receiver N/A Incoming Funds
date_range Mar 31, 2022
1,000,000 USD Government of Malaysia Receiver N/A Incoming Funds
date_range Mar 31, 2022
69,000,000 USD Provider N/A Receiver N/A Disbursement
date_range Feb 28, 2022
-18,900,000 USD Provider N/A Receiver N/A Disbursement
date_range Jan 31, 2022
3,013 USD Other investors Receiver N/A Incoming Funds
date_range Jan 31, 2022

Budget

0 USD
access_time Updated on Oct 17, 2022 07:02:09
View XML file here